Who's advisory committee on vaccine product development - Latest News Update, Information, Photos & Videos on Who's advisory committee on vaccine product development at Lokmat Times

Hyderabad-based vaccine manufacturer Biological E on Monday announced that it has been selected as a recipient of mRNA technology from the World Health Organisation (WHO) technology transfer hub.After examining a number of proposals from India, the WHO's Advisory Committee on Vaccine Product Development (ACPDV) selected Biological E Limited as a recipient of mRNA technology from the WHO technology transfer hub. WHO and their partners will work with the Indian government to develop a roadmap and put in place the necessary training and support for Biological E to start producing mRNA vaccines as soon as possible, said Biological E.Primarily set up to address the COVID-19 emergency, the WHO mRNA technology transfer hub has the potential to expand manufacturing capacity for other products as well, including treatments, and target other priorities.mRNA vaccines use a messenger RNA created in a laboratory to teach the human cells how to produce a protein that in turn initiates an immune response inside the body against a particular disease. The immune response will fight the actual virus as it gets into the body.At present, India has no COVID-19 vaccine made on an mRNA platform.Over the development, Biological E Managing Director Mahima Datla said, "We are excited about this remarkable milestone in our efforts to produce affordable vaccines for the world. We are very pleased with the trust that WHO places in our organisation, which adheres to the standards set by the WHO. This is also a reflection of our world-class processes, scale and effectiveness.""Biological E has been investing in mRNA technologies since last year. This new technology will definitely strengthen our resolve to develop and manufacture more vaccines in future. This partnership with WHO will enhance our ability to develop next-generation mRNA vaccines that could be more suitable globally and expand the reach of vaccines availability worldwide," Datla said.( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Pahalgam Terror Attack

Tahawwur Rana

IPL 2025

CM Devendra Fadnavis

Mumbai Local

Weather Update

Who's Advisory Committee On Vaccine Product Development, NewsFOLLOW

Who's advisory committee on vaccine product development, Latest News

National :Hyderabad-based Biological E to get mRNA technology from WHO to produce COVID-19 vaccines

Hyderabad-based vaccine manufacturer Biological E on Monday announced that it has been selected as a recipient of mRNA technology from the World Health Organisation (WHO) technology transfer hub. ...